-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Immuneering Corp annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- Immuneering Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $13,810,559, a 1309% increase year-over-year.
- Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $226,583,147, a 4172% increase from 2024.
- Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5,303,519, a 81% decline from 2023.
- Immuneering Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $28,441,073.